Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Insights
  3. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • NHS Solutions
  • Life Sciences Industry
  • Advancing UK Healthcare
  • Pharmacy Communications
NHS Solutions

Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.

Learn More
NHS Solutions
Life Sciences Industry

We believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.

Learn More
Life Sciences Industry Solutions
Advancing UK Healthcare

We are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.

Learn More
Advancing UK Healthcare Solutions
Pharmacy Communications

IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.

Learn More
MAIN/Insights
Insights/
BLOGS, WHITEPAPERS & CASE STUDIES

Explore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.

Learn More
NEWSROOM

Stay up to date on the latest news and press releases from IQVIA UK & Ireland.

Learn More

Report

"Our commitment to sustainability.

Learn More
MAIN/Contact Us
Contact Us/

Press Release

IQVIA selected to provide talent resourcing by EGO Pharmaceuticals to raise awareness on skincare

6 13, 2022

IQVIA™, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today announced their talent resourcing partnership with EGO Pharmaceuticals, a pioneering Australian skincare manufacturer. IQVIA and EGO Pharmaceuticals will work to build a passionate team of professionals to advance the appropriate and effective use of skincare treatments to improve patient outcomes.

The Australian-owned EGO Pharmaceuticals has led the way in the development, manufacture, and marketing of innovative skincare products for 60 years. Its QV Skincare range has an extensive list of dermatologically tested and healthcare professional recommended products that target dry and sensitive skin for babies, children, and adults.

With candidate profiles becoming more specialised, and speed to market being critical, the need for an agile personnel resourcing process is more important than ever. IQVIA’s unique ability to attract, assess and deploy high quality talent helps build teams that can create an impact instantly. IQVIA’s Contract Sales and Medical Solutions (CSMS) division provides commercial and technology solutions to improve patient outcomes for the healthcare and life sciences industry.

The team  assembled for the QV Skincare portfolio  is part of a year-long talent resourcing collaboration in which IQVIA’s CSMS division will be  EGO Pharmaceuticals’ provider of  sales and marketing personnel.

Joanna Collis, Head of Talent Acquisition CSMS, IQVIA UK & Ireland commented “We are thrilled to have been chosen as EGO Pharmaceuticals’ recruitment partner. We are looking forward to deploying our best practice recruitment processes, to hire the talent and skills they need. This partnership will enable the EGO business to focus on their strategic objectives of helping people restore and maintain skin health.”

Commenting on the partnership, Derek Murphy, Country Manager, UK, EGO Pharmaceuticals said “This is an exciting time of development for EGO Pharmaceuticals UK, bringing in the right people to complement our team, known as EgoZites, will be critical for us to deliver our plans. The Talent Acquisition team at IQVIA is already showing  itself to be a great partner and feel like an extension of our own team.”

Notes to Editor

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 79,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

About Ego Pharmaceuticals

Proudly Australian-owned, Ego Pharmaceuticals has led the way in the development, manufacture and marketing of innovative skincare products for 60 years. Our mission is to exist for people who want healthy skin. Ego is the specialist in skincare, backed by science. We make our products in Australia for the people of the world. We provide consistently high quality products, underpinned by heritage and integrity.

From its inception as a family business in 1953, Ego has grown to become a world leader, producing a comprehensive skin and health care range for sale in Australia and around the world. Our reputation is built on consistently delivering effective, high-quality and innovative products to meet a diverse range of needs, and we are committed to creating the best possible skin therapies for our customers.

For more information visit: https://www.egopharm.com/gb/en/about-us.html

Media enquiries to Peter Duncan, Message Matters on 07740 469949 or peter@messagematters.co.uk

Contact Us